—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Roivant Sciences Ltd (ROIV) — Technical state

As of 2026-11-02 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 37 out of 100 (momentum 82 · quality 21 · valuation 37), as of 2026-11-03.
  • Signal: Pullback inside an uptrend stack — Trades -2% vs the 50-day and +13.7% vs the 200-day average, 15.6% below the 52-week high and +86% off the 52-week low. Computed from daily closes. (as of 2026-11-02)
  • Trend: Roivant Sciences Ltd trades 2.0% below its 50-day and 13.7% above its 200-day moving average. (as of 2026-11-02)

Roivant Sciences discovers, develops and aims to commercialise new medicines, mainly in autoimmune and cardiopulmonary disease. Its pipeline includes antibody and small-molecule candidates for conditions such as pulmonary hypertension, thyroid eye disease and several IgG-mediated autoimmune disorders, alongside lipid-nanoparticle and ligand-conjugate delivery platforms.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ROIV overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Pullback inside an uptrend stack

Trades -2% vs the 50-day and +13.7% vs the 200-day average, 15.6% below the 52-week high and +86% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the ROIV chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-02

Quick answers

What is the current Closelooknet signal on ROIV?

Pullback inside an uptrend stack — Trades -2% vs the 50-day and +13.7% vs the 200-day average, 15.6% below the 52-week high and +86% off the 52-week low. Computed from daily closes. As of 2026-11-02; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is ROIV above its 50-day and 200-day moving averages?

As of 2026-11-02, Roivant Sciences Ltd trades -2% below its 50-day and +13.7% above its 200-day average, with the 20-day +1.2% away.

How far is ROIV from its 52-week high?

15.6% below the 52-week high and 86% above the 52-week low, as of 2026-11-02.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.